Delivery Order SPE2DE24DA010-SPE2D625F9TZ4
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
- This is a $14,850.00 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large medical device manufacturer, for the delivery of various cardiovascular medical devices and related supplies. The contract is not set aside and has an ultimate completion date of September 13, 2024. Abbott Laboratories, through its Abbott Vascular Inc. division, is a key supplier of advanced medical technologies to federal healthcare systems, particularly the...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $66,000 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as MITRCLIP and issued without set-aside provisions under full and open competition, calls for delivery to Santa Clara, California. This delivery order represents a task order against Abbott's broader federal contract...
- This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
- This is a fixed-price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $28,350.00 contract is for the delivery of cardiovascular medical devices and related services, such as stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract does not have a set-aside designation, indicating full and open...
- This federal contract award was issued by the Medical Supply Chain, a Defense agency, to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $25,715.85 fixed-price delivery order contract, awarded on July 9, 2025, has an ultimate completion date of July 14, 2025 and does not utilize a set-aside designation. The contract requires Abbott Laboratories to provide a range of cardiovascular medical devices and technologies, including stents, pacemakers, heart valves, implantable...
- This federal contract award was made by the Medical Supply Chain, a division of the Defense agency, to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $5,695.00 fixed-price with economic price adjustment delivery order contract is for the provision of cardiovascular medical devices and related services to support federal healthcare systems, particularly the Department of Veterans Affairs (VA) and the Defense Logistics Agency (DLA). The contract has an ultimate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The $46,183.00 fixed-price delivery order contract is for the delivery of various cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has no set-aside designation, indicating full and open competition. Abbott Laboratories Inc. has secured...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F9TZ4Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,495 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with an ultimate completion date of August 4, 2025. This delivery order, which contains no set-aside designation indicating full and open competition, represents a call against a larger indefinite delivery contract vehicle. The work will be performed in Santa Clara, California, and involves the supply of cardiovascular medical technologies and related products consistent with Abbott's core capabilities in advanced medical device procurement for federal healthcare systems. As a subsidiary of Abbott Laboratories Inc., Abbott Vascular Inc. has established itself as a critical supplier of sophisticated cardiovascular medical devices to federal agencies, particularly through the Defense Logistics Agency and the Department of Veterans Affairs. The company's extensive portfolio includes stents, pacemakers, heart valves, and other advanced implantable devices that support complex medical procedures. This delivery order aligns with Abbott's broader strategic role in federal healthcare procurement, where the parent company maintains multiple significant indefinite delivery vehicles worth over $117 million with the Defense Logistics Agency for comprehensive procedural packages and cardiovascular technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/30/25 |